651 related articles for article (PubMed ID: 19211226)
1. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
[TBL] [Abstract][Full Text] [Related]
2. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose.
de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O
Nutrition; 2013; 29(11-12):1300-3. PubMed ID: 19131213
[TBL] [Abstract][Full Text] [Related]
3. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
[TBL] [Abstract][Full Text] [Related]
4. Circulating adipocytokines in obese nondiabetic patients in relationship with cardiovascular risk factors, anthropometry and resting-energy expenditure.
de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O; Romero E
Ann Nutr Metab; 2007; 51(5):416-20. PubMed ID: 18025813
[TBL] [Abstract][Full Text] [Related]
5. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of adipocytokines in obese children with insulin resistance.
Taşçilar ME; Cekmez F; Meral C; Pirgon O; Tanju IA; Canpolat FE; Abaci A; Tapan S; Eker I
Turk J Pediatr; 2011; 53(3):269-73. PubMed ID: 21980807
[TBL] [Abstract][Full Text] [Related]
7. Relation of phase angle tertiles with blood adipocytokines levels, insulin resistance and cardiovascular risk factors in obese women patients.
de Luis DA; Aller R; Romero E; Dueñas A; Perez Castrillon JL
Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):521-6. PubMed ID: 20712259
[TBL] [Abstract][Full Text] [Related]
8. High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients.
Labruna G; Pasanisi F; Nardelli C; Caso R; Vitale DF; Contaldo F; Sacchetti L
Obesity (Silver Spring); 2011 Jul; 19(7):1492-6. PubMed ID: 21183936
[TBL] [Abstract][Full Text] [Related]
9. Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Perez Castrillon JL; Dueñas A
Diabetes Res Clin Pract; 2009 May; 84(2):174-8. PubMed ID: 19243851
[TBL] [Abstract][Full Text] [Related]
10. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
[TBL] [Abstract][Full Text] [Related]
11. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
[TBL] [Abstract][Full Text] [Related]
12. Circulating adipocytokines in morbid obese patients, relation with cardiovascular risk factors and anthropometric parameters.
de Luis DA; González Sagrado M; Conde R; Aller R; Izaola O; Castro MJ
Nutr Hosp; 2011; 26(1):91-6. PubMed ID: 21519734
[TBL] [Abstract][Full Text] [Related]
13. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
[TBL] [Abstract][Full Text] [Related]
14. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B; Perez Castrillon JL
Eur Rev Med Pharmacol Sci; 2009; 13(6):413-8. PubMed ID: 20085121
[TBL] [Abstract][Full Text] [Related]
15. Association of adipokines with obesity in children and adolescents.
Jaleel A; Aheed B; Jaleel S; Majeed R; Zuberi A; Khan S; Ahmed B; Shoukat F; Hashim H
Biomark Med; 2013 Oct; 7(5):731-5. PubMed ID: 24044565
[TBL] [Abstract][Full Text] [Related]
16. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
[TBL] [Abstract][Full Text] [Related]
17. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
18. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol.
Jin H; Jiang B; Tang J; Lu W; Wang W; Zhou L; Shang W; Li F; Ma Q; Yang Y; Chen M
Diabetes Res Clin Pract; 2008 Mar; 79(3):412-8. PubMed ID: 18241953
[TBL] [Abstract][Full Text] [Related]
19. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.
Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY
Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030
[TBL] [Abstract][Full Text] [Related]
20. Adipokines and cardiometabolic function: How are they interlinked?
Schutte AE; Huisman HW; Schutte R; van Rooyen JM; Malan L; Fourie CM; Malan NT
Regul Pept; 2010 Sep; 164(2-3):133-8. PubMed ID: 20615436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
